Trial Profile
Efficacy of paliperidone palmitate long acting injectable in patients with schizophrenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2015
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 13 Jan 2015 New trial record